Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels
    Arun Anantharam, Steven M. Markowitz and Geoffrey W. Abbott
    Journal of Pharmacology and Experimental Therapeutics December 2003, 307 (3) 831-838; DOI: https://doi.org/10.1124/jpet.103.054569
  • You have access
    Steroid Hormone Interactions with Target Cells: Cross Talk between Membrane and Nuclear Pathways
    Mary C. Farach-Carson and Paul J. Davis
    Journal of Pharmacology and Experimental Therapeutics December 2003, 307 (3) 839-845; DOI: https://doi.org/10.1124/jpet.103.055038
  • You have access
    Protease-Activated Receptors: New Concepts in Regulation of G Protein-Coupled Receptor Signaling and Trafficking
    Joann Trejo
    Journal of Pharmacology and Experimental Therapeutics November 2003, 307 (2) 437-442; DOI: https://doi.org/10.1124/jpet.103.052100
  • You have access
    Inflammation and Drug Idiosyncrasy—Is There a Connection?
    Robert A. Roth, James P. Luyendyk, Jane F. Maddox and Patricia E. Ganey
    Journal of Pharmacology and Experimental Therapeutics October 2003, 307 (1) 1-8; DOI: https://doi.org/10.1124/jpet.102.041624
  • You have access
    The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development
    A. V. Terry and J. J. Buccafusco
    Journal of Pharmacology and Experimental Therapeutics September 2003, 306 (3) 821-827; DOI: https://doi.org/10.1124/jpet.102.041616
  • You have access
    Nociceptin/Orphanin FQ and Its Receptor—Potential Targets for Pain Therapy?
    Hanns Ulrich Zeilhofer and Girolamo Calò
    Journal of Pharmacology and Experimental Therapeutics August 2003, 306 (2) 423-429; DOI: https://doi.org/10.1124/jpet.102.046979
  • You have access
    Ontogenesis of β-Adrenoceptor Signaling: Implications for Perinatal Physiology and for Fetal Effects of Tocolytic Drugs
    Theodore A. Slotkin, J. Todd Auman and Frederic J. Seidler
    Journal of Pharmacology and Experimental Therapeutics July 2003, 306 (1) 1-7; DOI: https://doi.org/10.1124/jpet.102.048421
  • You have access
    Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans
    David S. Goldstein, Graeme Eisenhofer and Irwin J. Kopin
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 800-811; DOI: https://doi.org/10.1124/jpet.103.049270
  • You have access
    Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile?
    Lawrence H. Lash, Ronald N. Hines, Frank J. Gonzalez, Timothy R. Zacharewski and Mark A. Rothstein
    Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 403-409; DOI: https://doi.org/10.1124/jpet.102.039925
  • You have access
    The Thyrotropin-Releasing Hormone (TRH) Hypothesis of Homeostatic Regulation: Implications for TRH-Based Therapeutics
    Keith A. Gary, Kevin A. Sevarino, George G. Yarbrough, Arthur J. Prange and Andrew Winokur
    Journal of Pharmacology and Experimental Therapeutics May 2003, 305 (2) 410-416; DOI: https://doi.org/10.1124/jpet.102.044040

Pages

  • Previous
  • Next
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 16
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics